Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
Por um escritor misterioso
Descrição
Frontiers in Pharmacology
ancestry informative markers - List of Frontiers' open access articles
Genome wide association studies for treatment‐related adverse effects of pediatric acute lymphoblastic leukemia - Franca - 2021 - WIREs Mechanisms of Disease - Wiley Online Library
Frontiers Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
Frontiers Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers
Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response
Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients
Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
PDF) Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia
de
por adulto (o preço varia de acordo com o tamanho do grupo)
